CPRX didnt cataylze anything
weekly data, regression analysis hit upper band, major candle stick wick.. blow that candle out! due to offering 8 million new shares diluting value.
FIB can retrace back to $2.5 if we arent careful, already did a month ago .
On the medical side the product does have staying power, just a matter of selling it, expensive price tag though. 1st in class
As per the stock, buy low sell high, the option calls Dec 2019 have it at $10.
Ride the roller coaster my friends.
cheers , happy trading!
FIB can retrace back to $2.5 if we arent careful, already did a month ago .
On the medical side the product does have staying power, just a matter of selling it, expensive price tag though. 1st in class
As per the stock, buy low sell high, the option calls Dec 2019 have it at $10.
Ride the roller coaster my friends.
cheers , happy trading!
Komen:
Reverse course.. company holds off NOT issuing 8mill new stock.. after a more than not appreciative response.